LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
147,700
+900 (0.61%)
Jun 2, 2026, 3:30 PM KST
Market Cap5.44T +48.8%
Revenue (ttm)125.87B +12.4%
Net Income-138.08B
EPS-3,790.81
Shares Out 36.85M
PE Ration/a
Forward PE2,101.12
Dividendn/a
Ex-Dividend Daten/a
Volume475,787
Open147,000
Previous Close146,800
Day's Range142,700 - 155,900
52-Week Range102,600 - 225,000
Beta0.50
AnalystsBuy
Price Target228,333.33 (+54.59%)
Earnings DateMay 18, 2026

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements